About CEPI
CEPI is a company based in Oslo (Norway) founded in 2017. It operates as a AI-as-a-Service and Professional Services. The company has 89 employees as of January 14, 2025. CEPI offers products and services including Vaccine Development and AI Pandemic Preparedness Engine.
- Headquarter Oslo, Norway
- Employees 89 as on 14 Jan, 2025
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Coalition For Epidemic Preparedness Innovations
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$449.33 K (USD), Grant
Jun 01, 2023
- Investors
-
Employee Count
89
as on Jan 14, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CEPI
CEPI offers a comprehensive portfolio of products and services, including Vaccine Development and AI Pandemic Preparedness Engine.
Vaccines are developed to combat epidemic pandemic threats.
AI platform is built for pandemic preparedness solutions.
People of CEPI
Unlock access to complete
Funding Insights of CEPI
Investors in CEPI
CEPI has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for CEPI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CEPI
Investment portfolio details for CEPI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CEPI
Detailed financials for CEPI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cepi Comparisons
Peer comparison for CEPI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CEPI
Detailed competitors of CEPI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cepi
Complete news archive for CEPI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CEPI
CEPI was founded in 2017 and raised its 1st funding round 2 years after it was founded.
CEPI is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Frederik Kristensen is the current CEO of CEPI.
As of Jan 14, 2025, the latest employee count at CEPI is 89.
CEPI, the Coalition for Epidemic Preparedness Innovations, is dedicated to accelerating the development of vaccines and biologic countermeasures against epidemic and pandemic threats. Programs are led to reduce global health risks through research, innovative technologies, and manufacturing capacity expansion in underserved regions. Partnerships are formed with governments, industry, and academia to ensure equitable access to solutions. AI capabilities are harnessed to build a Pandemic Preparedness Engine, while priority pathogens like Lassa fever, Mpox, and Rift Valley fever are targeted. A systems approach is adopted to address emerging infectious diseases across borders.
CEPI offers Vaccine Development and AI Pandemic Preparedness Engine.
CEPI has 1 investor. Key investors include European Union.